BLKBRD Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-57,664
Closed -$2.12M 12
2026
Q1
$2.12M Sell
57,664
-9,880
-15% -$468K 5.54% 12
2025
Q4
$3.44M Sell
67,544
-211,470
-76% -$10.8M 4.62% 15
2025
Q3
$15.5M Buy
+279,014
New +$16.3M 4.31% 16

Other funds holding NVO

BLKBRD Asset Management's NVO Position: Q2 2026 in Review

BLKBRD Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 57,664 shares — an estimated $2.12M sold.

BLKBRD Asset Management first reported a position in NVO in Q3 2025 and held it in 3 quarters. The position peaked at $15.5M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • BLKBRD Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • BLKBRD Asset Management sold 57,664 Novo Nordisk shares in Q2 2026, an estimated $2.12M.
  • BLKBRD Asset Management first reported a position in Novo Nordisk in Q3 2025 and held it in 3 quarters.
  • BLKBRD Asset Management's Novo Nordisk position peaked at $15.5M in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on BLKBRD Asset Management's 13F filing for Q2 2026.